Delivery Order SPE2DR25D2206-SPE2DR26F9DW9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,597.62 to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count units) on November 13, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $14,597.62. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. The order is scheduled for ultimate completion by December 24, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $27,703.52 to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Pomalyst (pomalidomide) 4 mg capsules in a 21-count package. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Pomalyst 1 mg capsules (100-count units) with a ceiling value of $292,457.73. This firm fixed price delivery order, with an ultimate completion date of May 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $12,084.50, this order is for the supply of 4562914807 POMALYST 4 MG CAPSULE 21S to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. No set-aside designation was applied to this award. As a...
- This is a $114,147.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pomalyst 1 mg capsules, a specialty medication used for the treatment of certain types of cancer. The contract has a period of performance through January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,248.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This non-competitive delivery order was issued on December 4, 2025, with an ultimate completion date of the same day, and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp on December 6, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,049.10 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $83,743.39 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 7, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by December 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9DW9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count packages) on December 2, 2025, with a ceiling value of $43,792.86 and completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. Through this contractual relationship, AmerisourceBergen Drug Corp serves multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, providing critical pharmaceutical support for Department of Defense operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.8k | 12/1/25 |